State of Wisconsin Investment Board
CRNX icon

State of Wisconsin Investment Board’s Crinetics Pharmaceuticals CRNX Stock Holding History

State of Wisconsin Investment Board’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.37M Buy
65,232
+9,671
+17% +$432K 0.01% 1346
2025
Q4 		$2.59M Sell
55,561
-1,464
-3% -$65.2K 0.01% 1317
2025
Q3 		$2.38M Sell
57,025
-7,562
-12% -$242K 0.01% 1296
2025
Q2 		$1.86M Buy
64,587
+1,032
+2% +$31.9K ﹤0.01% 1336
2025
Q1 		$2.13M Sell
63,555
-11,548
-15% -$431K 0.01% 1216
2024
Q4 		$3.84M Buy
75,103
+9,709
+15% +$543K 0.01% 1052
2024
Q3 		$3.34M Buy
65,394
+4,978
+8% +$257K 0.01% 1117
2024
Q2 		$2.71M Buy
60,416
+10,305
+21% +$476K 0.01% 1180
2024
Q1 		$2.35M Sell
50,111
-7,657
-13% -$300K 0.01% 1198
2023
Q4 		$2.06M Buy
57,768
+7,496
+15% +$230K 0.01% 1232
2023
Q3 		$1.5M Buy
50,272
+10,874
+28% +$224K ﹤0.01% 1316
2023
Q2 		$710K Buy
39,398
+4,631
+13% +$92.3K ﹤0.01% 1622
2023
Q1 		$558K Sell
34,767
-1,027
-3% -$19K ﹤0.01% 1823
2022
Q4 		$655K Sell
35,794
-2,303
-6% -$40.6K ﹤0.01% 1777
2022
Q3 		$748K Buy
38,097
+1,527
+4% +$31.1K ﹤0.01% 1710
2022
Q2 		$682K Sell
36,570
-24,730
-40% -$494K ﹤0.01% 1905
2022
Q1 		$1.35M Sell
61,300
-6,900
-10% -$140K ﹤0.01% 1584
2021
Q4 		$1.94M Buy
68,200
+29,600
+77% +$730K ﹤0.01% 1286
2021
Q3 		$813K Hold
38,600
– – ﹤0.01% 1509
2021
Q2 		$728K Hold
38,600
– – ﹤0.01% 1562
2021
Q1 		$590K Hold
38,600
– – ﹤0.01% 1542
2020
Q4 		$545K Sell
38,600
-4,800
-11% -$66.9K ﹤0.01% 1505
2020
Q3 		$680K Buy
43,400
+26,300
+154% +$402K ﹤0.01% 1387
2020
Q2 		$300K Hold
17,100
– – ﹤0.01% 1558
2020
Q1 		$251K Buy
17,100
+500
+3% +$10.2K ﹤0.01% 1538
2019
Q4 		$416K Hold
16,600
– – ﹤0.01% 1486
2019
Q3 		$250K Buy
16,600
+6,900
+71% +$134K ﹤0.01% 1480
2019
Q2 		$242K Buy
9,700
+200
+2% +$4.95K ﹤0.01% 1467
2019
Q1 		$216K Buy
9,500
+2,100
+28% +$51.6K ﹤0.01% 1458
2018
Q4 		$222K Buy
+7,400
New +$208K ﹤0.01% 1445

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State of Wisconsin Investment Board's CRNX Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Crinetics Pharmaceuticals (CRNX) stake by 17% in Q1 2026, buying an estimated $432K and bringing the position to 65,232 shares worth $2.37M. The position accounts for 0.01% of the portfolio, ranked #1346.

State of Wisconsin Investment Board first reported a position in CRNX in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.84M in Q4 2024. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

  • State of Wisconsin Investment Board held 65,232 shares of Crinetics Pharmaceuticals worth $2.37M as of Q1 2026.
  • State of Wisconsin Investment Board bought 9,671 Crinetics Pharmaceuticals shares in Q1 2026, an estimated $432K.
  • Crinetics Pharmaceuticals made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1346 holding.
  • State of Wisconsin Investment Board first reported a position in Crinetics Pharmaceuticals in Q4 2018 and has held it in 30 quarters since.
  • State of Wisconsin Investment Board's Crinetics Pharmaceuticals position peaked at $3.84M in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.